111 Inc ADR (YI) Stock Price, Quote & News

Company Profile

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy o...

Industry: Medical Distribution

Sector: Healthcare

Phone: 86 21 2053 6666

Website: corporate.111.com.cn

Address:

No.295 ZuChongZhi Road, 3-4/F Pudong New Area, Shanghai, China

Sobo90 Apr. 27 at 3:41 PM

$YI estimating this to reach $130M market cap. Push the $15 mark.

1 · Reply

sampeper Apr. 24 at 1:51 PM

$BBIO Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $YI https://news.futunn.com/en/post/71734644/piper-sandler-maintains-bridgebio-pharma-bbious-with-buy-rating-maintains?level=1&data_ticket=1774896646963134

0 · Reply

dark_gamma Apr. 21 at 7:24 PM

$AAL OPTIONS LEVELS Date: 2026-04-21 Key Market Levels: - Call Wall: $12.00 - Put Wall: $11.50 - Gamma Flip: $11.50 Whale Positioning Indicators: - Dark Gamma: $RETC - Whale 1: $12.18 - Whale 2: $12.07 - Whale 3: $12.29 - Whale 4: $13.02 - Whale 5: $11.84 Volatility Ranges: - Upper Bound: 1σ $12.69 | 2σ $13.14 - Lower Bound: 1σ $11.79 | 2σ $YI Daily Market Updates: Levels updated daily. Disclaimer: This information is provided for general purposes only and should not be considered as personalized investment advice. Trading involves risk, and it is essential to conduct thorough research and consult with a financial expert before making any investment decisions. #AAL #Options #Trading

0 · Reply

OfficialStocktwitsUser Apr. 14 at 3:30 PM

$YI RSI: 55.51, MACD: -0.0838 Vol: 0.18, MA20: 6.53, MA50: 7.15 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

JohnTill Apr. 9 at 11:38 PM

$YI December 31, 2025 cash = $87.4 million. December 31, 2025 2020 IPO debit = $160.0 million. February 2026, the Company made repayments of approximately RMB189.0 million (US$27.0 million) to all investors of 1 Pharmacy Technology. Correct me if I am wrong but according to the annual report item the remaining $133 million is due by September 30, 2026, which would bankrupt them. Something need to happen fast. Stock is acting like something is in the works and nothing like playing chicken with the clock ticking. Not saying they are going under and just pointing out the obvious that everyone can see.

3 · Reply

focafoca99 Apr. 9 at 7:51 PM

$YI said its shift to an asset-light model delivered non-GAAP operating profitability and positive operating cash flow in both Q4 and full-year 2025.

0 · Reply

i_jw Apr. 8 at 3:52 PM

$YI So what we have here together with $GHG is no informal Q4 report in March, with YI very large unusual volume spikes hitting the ask 2-3 months ago and a clear incentive to sell/take private.

2 · Reply

i_jw Apr. 8 at 3:25 PM

$YI No announcement of Q4 results in late march, a break with previous years.

1 · Reply

Sobo90 Mar. 31 at 1:10 PM

$YI Inverse cup handle with $6.04 support. May be a $35 stock when its all said and done.

1 · Reply

i_jw Mar. 30 at 2:39 PM

$YI Back in this thing. If this was some run of the mill pump and dump we should have seen the exit volume by now. Something will happen here. The large volume spike on YSB on the same day (who just happens to be on an acquisition spree, and has a lot of spare cash) is also too much of a coincidence.

0 · Reply

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Dec 17, 2025, 1:00 AM EST - 5 months ago

111, Inc. Announces Third Quarter 2025 Unaudited Financial Results

Sep 17, 2025, 2:00 AM EDT - 8 months ago

111, Inc. Announces Second Quarter 2025 Unaudited Financial Results

Jun 19, 2025, 3:03 AM EDT - 11 months ago

111, Inc. Announces First Quarter 2025 Unaudited Financial Results

Mar 26, 2025, 11:00 AM EDT - 1 year ago

111, Inc. Transcript: Status Update

Mar 20, 2025, 7:30 AM EDT - 1 year ago

111, Inc. Earnings Call Transcript: Q4 2024

Mar 20, 2025, 1:00 AM EDT - 1 year ago

111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Mar 12, 2025, 7:00 AM EDT - 1 year ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025

Feb 20, 2025, 5:00 AM EST - 1 year ago

111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow

2025-02-11T13:07:16.000Z - 1 year ago

111, Inc. regains Nasdaq compliance

Feb 11, 2025, 8:00 AM EST - 1 year ago

111, Inc. Regains Compliance with NASDAQ Requirement

Jan 22, 2025, 4:30 AM EST - 1 year ago

Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc.

2025-01-08T10:10:26.000Z - 1 year ago

111, Inc. announces one-for-twenty ADS ratio change

Jan 8, 2025, 5:00 AM EST - 1 year ago

111, Inc. Announces ADS Ratio Change

Dec 6, 2024, 11:00 AM EST - 1 year ago

111, Inc. Transcript: Fireside Chat

Nov 27, 2024, 7:30 AM EST - 1 year ago

111, Inc. Earnings Call Transcript: Q3 2024

Nov 27, 2024, 1:00 AM EST - 1 year ago

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

Nov 21, 2024, 5:00 AM EST - 1 year ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024

Nov 4, 2024, 6:00 AM EST - 1 year ago

111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow

Nov 4, 2024, 5:00 AM EST - 1 year ago

111, Inc. Announces Change to Board of Directors

Oct 30, 2024, 12:00 PM EDT - 1 year ago

111, Inc. Transcript: Status Update

Oct 22, 2024, 5:10 AM EDT - 1 year ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024

Oct 18, 2024, 5:00 AM EDT - 1 year ago

111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow

2024-10-10T10:15:32.000Z - 1 year ago

111, Inc. announces South, Central China fulfillment centers begin operations

Oct 10, 2024, 6:02 AM EDT - 1 year ago

111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China

2024-09-27T21:30:17.000Z - 1 year ago

111, Inc. discloses Nasdaq listing deficiency notice

Sep 27, 2024, 5:00 PM EDT - 1 year ago

111, Inc. Announces Receipt of Notification from Nasdaq

Sep 18, 2024, 8:15 AM EDT - 1 year ago

Synthetic Fiber Market Size is Anticipated to Reach USD 111.9 billion, Advancing at a CAGR of 4.8% by 2034: Transparency Market Research Inc.

Sep 13, 2024, 7:30 AM EDT - 1 year ago

111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation

Sep 5, 2024, 11:00 AM EDT - 1 year ago

111, Inc. Transcript: Fireside Chat with Water Tower Research

Aug 29, 2024, 7:30 AM EDT - 1 year ago

111, Inc. Earnings Call Transcript: Q2 2024

2024-08-29T09:17:09.000Z - 1 year ago

111, Inc. reports Q2 EPS (RMB 0.16) vs. (RMB 0.68) last year

Aug 29, 2024, 2:00 AM EDT - 1 year ago

111, Inc. Announces Second Quarter 2024 Unaudited Financial Results

Aug 27, 2024, 8:00 AM EDT - 1 year ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on September 5, 2024

Jul 29, 2024, 1:00 AM EDT - 1 year ago

111 to Announce Second Quarter 2024 Unaudited Financial Results on August 29, 2024 - Conference Call to Follow

2024-07-19T12:48:41.000Z - 1 year ago

111, Inc. appoints new auditor

Jul 19, 2024, 8:45 AM EDT - 1 year ago

111 Announces Appointment of New Auditor

Jul 17, 2024, 1:31 AM EDT - 1 year ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024

2024-06-11T09:14:27.000Z - 2 years ago

111, Inc. enters direct supply partnership with Beijing Scrianen Pharmaceutical

Jun 11, 2024, 3:57 AM EDT - 2 years ago

111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility

May 23, 2024, 7:30 AM EDT - 2 years ago

111, Inc. Earnings Call Transcript: Q1 2024

May 23, 2024, 4:43 AM EDT - 2 years ago

111, Inc. Announces First Quarter 2024 Unaudited Financial Results

Apr 30, 2024, 2:30 AM EDT - 2 years ago

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow

Mar 21, 2024, 7:30 AM EDT - 2 years ago

111, Inc. Earnings Call Transcript: Q4 2023

Mar 21, 2024, 4:47 AM EDT - 2 years ago

111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Mar 1, 2024, 4:00 AM EST - 2 years ago

111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow

2024-02-27T14:01:15.000Z - 2 years ago

111, Inc. receives withdrawal of going private proposals

Feb 27, 2024, 8:58 AM EST - 2 years ago

111 Announces Receipt of Withdrawal of Going Private Proposal

Nov 30, 2023, 7:30 AM EST - 2 years ago

111, Inc. Earnings Call Transcript: Q3 2023

Nov 30, 2023, 1:00 AM EST - 2 years ago

111, Inc. Announces Third Quarter 2023 Unaudited Financial Results

Nov 13, 2023, 12:10 AM EST - 2 years ago

111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow

Aug 24, 2023, 7:30 AM EDT - 2 years ago

111, Inc. Earnings Call Transcript: Q2 2023

Aug 24, 2023, 2:00 AM EDT - 2 years ago

111, Inc. Announces Second Quarter 2023 Unaudited Financial Results

Jul 31, 2023, 5:59 AM EDT - 3 years ago

111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow

Jun 15, 2023, 7:30 AM EDT - 3 years ago

111, Inc. Earnings Call Transcript: Q1 2023

Jun 15, 2023, 1:22 AM EDT - 3 years ago

111, Inc. Announces First Quarter 2023 Unaudited Financial Results

May 25, 2023, 2:05 AM EDT - 3 years ago

111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow

Mar 23, 2023, 7:30 AM EDT - 3 years ago

111, Inc. Earnings Call Transcript: Q4 2022

Mar 23, 2023, 2:17 AM EDT - 3 years ago

111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Mar 2, 2023, 2:35 AM EST - 3 years ago

111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow

Feb 16, 2023, 12:33 AM EST - 3 years ago

111, Inc. Hosts Hua Medicine Launches First Official Flagship Store

Dec 1, 2022, 7:30 AM EST - 3 years ago

111, Inc. Earnings Call Transcript: Q3 2022

Dec 1, 2022, 2:33 AM EST - 3 years ago

111, Inc. Announces Third Quarter 2022 Unaudited Financial Results

Nov 8, 2022, 1:09 AM EST - 3 years ago

111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow

Sep 23, 2022, 12:30 AM EDT - 3 years ago

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Sep 9, 2022, 5:53 AM EDT - 3 years ago

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

Aug 25, 2022, 7:30 AM EDT - 4 years ago

111, Inc. Earnings Call Transcript: Q2 2022

Aug 25, 2022, 2:18 AM EDT - 4 years ago

111, Inc. Announces Second Quarter 2022 Unaudited Financial Results

Aug 5, 2022, 2:26 AM EDT - 4 years ago

111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow

Jun 16, 2022, 7:30 AM EDT - 4 years ago

111, Inc. Earnings Call Transcript: Q1 2022

Jun 16, 2022, 3:58 AM EDT - 4 years ago

111, Inc. Announces First Quarter 2022 Unaudited Financial Results

May 26, 2022, 4:59 AM EDT - 4 years ago

111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow

May 5, 2022, 5:18 AM EDT - 4 years ago

111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act

Apr 13, 2022, 5:02 AM EDT - 4 years ago

111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai's Fight Against Covid-19 Pandemic

Sobo90 Apr. 27 at 3:41 PM

$YI estimating this to reach $130M market cap. Push the $15 mark.

1 · Reply

sampeper Apr. 24 at 1:51 PM

0 · Reply

dark_gamma Apr. 21 at 7:24 PM

0 · Reply

OfficialStocktwitsUser Apr. 14 at 3:30 PM

0 · Reply

JohnTill Apr. 9 at 11:38 PM

3 · Reply

focafoca99 Apr. 9 at 7:51 PM

$YI said its shift to an asset-light model delivered non-GAAP operating profitability and positive operating cash flow in both Q4 and full-year 2025.

0 · Reply

i_jw Apr. 8 at 3:52 PM

$YI So what we have here together with $GHG is no informal Q4 report in March, with YI very large unusual volume spikes hitting the ask 2-3 months ago and a clear incentive to sell/take private.

2 · Reply

i_jw Apr. 8 at 3:25 PM

$YI No announcement of Q4 results in late march, a break with previous years.

1 · Reply

Sobo90 Mar. 31 at 1:10 PM

$YI Inverse cup handle with $6.04 support. May be a $35 stock when its all said and done.

1 · Reply

i_jw Mar. 30 at 2:39 PM

0 · Reply

i_jw Mar. 25 at 8:12 PM

$YI No large bid volume since the last spike, so don't think it was a pump and dump. And YSB bought out 1bn RMB for a sales multiple of 1x. YI is trading at <0.1x sales here. Althought that 1bn rmb was growing while YI isn't. But still...

0 · Reply

Mr__G Mar. 23 at 12:17 PM

$YI something is cooking here.

0 · Reply

dark_gamma Mar. 18 at 2:23 PM

$AAL OPTIONS ANALYSIS Date: 2026-03-18 KEY SUPPORT AND RESISTANCE LEVELS: Call Wall: $11.00 Put Wall: $10.50 Gamma Flip Point: $YI WHALE POSITIONING AND SENTIMENT: Dark Gamma Indicator: $10.86 Whale 1: $10.41 Whale 2: $10.30 Whale 3: $10.64 Whale 4: $10.76 Whale 5: $10.53 VOLATILITY RANGES AND PRICE EXTREMES: Upper Volatility Range: 1σ $11.26 | 2σ $11.66 Lower Volatility Range: 1σ $10.46 | 2σ $10.06 Please note that these levels are subject to change and may not reflect the current market situation. For daily updates, follow our analysis. Disclaimer: This analysis is for informational purposes only and should not be considered as investment advice.

0 · Reply

dark_gamma Mar. 17 at 1:37 PM

$CRCL OPTIONS LEVELS Date: 2026-03-17 KEY LEVELS TO WATCH: - Call Wall: $125.00 - Put Wall: $121.00 - Gamma Flip Point: $126.00 WHALE POSITIONING INDICATES: - Dark Gamma Position: $124.07 - Top Whale Position: $125.83 - Other Whale Positions: $115.38, $112.81, $115.00, $114.00 VOLATILITY RANGES TO CONSIDER: - Upper Volatility Boundary: 1σ at $132.08, 2σ at $138.33 - Lower Volatility Boundary: 1σ at $119.58, 2σ at $YI DAILY LEVELS UPDATE AVAILABLE → Follow dark_gamma for latest updates. Disclaimer: The information provided is for educational purposes only and should not be considered as investment advice.

0 · Reply

htw7448 Mar. 15 at 8:22 AM

$YI waiting for the third wave

0 · Reply

AlwaysRational Mar. 12 at 4:39 AM

$YI I'm glad I peeled out my remaining position when it was still above $8. There's no way I was leaving profits on the table when this kind of dive was inevitable.

2 · Reply

BillionerOfKing Mar. 10 at 7:50 PM

$YI Current Stock Price: $6.85

0 · Reply

OfficialStocktwitsUser Mar. 2 at 9:56 AM

$YI RSI: 60.85, MACD: 0.7367 Vol: 0.42, MA20: 7.85, MA50: 5.52 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

CapitalRadiance Feb. 20 at 2:12 PM

$YI 111 Inc operates digital healthcare platforms in China. Revenue growth depends on policy and demand normalization. Margin pressure persists.

0 · Reply

MarketMetronome Feb. 17 at 3:38 PM

$YI 111 Inc operates a Chinese healthcare e-commerce platform, facing regulatory uncertainty and competitive pressures.

0 · Reply

AlwaysRational Feb. 11 at 7:26 PM

$YI Nice stairstepping action. I might as well hold for a while longer.

0 · Reply

htw7448 Feb. 10 at 8:46 PM

$YI pure strenght continues

0 · Reply

Market Cap	49.88M
Revenue (ttm)	1.80B
Net Income (ttm)	-9.65M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-0.54%
Debt to Equity Ratio	-0.26

Volume	11,500
Avg Vol	12,772
Day's Range	N/A - N/A
Shares Out	8.64M
Stochastic %K	52%
Beta	0.66
Analysts	Strong Buy
Price Target	$16.00